Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
3
×
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
3
×
abbvie
astrazeneca
avexis
biotech
bristol-myers squibb
celgene
deals
eli lilly
gene therapy
genentech
johnson & johnson
microbiome
What
bio
fda
3
×
news
3
×
roundup
drug
drugs
approved
aren’t
august
biotech
busy
companies
days
decisions
developers
devices
digital
disease
epidemic
fatty
frenzied
gene
growing
help
imminent
known
led
legacy
liver
long
medicare
merck
moves
nash
nods
noteworthy
opioid
past
patients
prices
Language
unset
Current search:
news
×
fda
×
" new york blog main "
×
" wisconsin top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More